Barry L. Templin Form 3 Filing for PROCEPT BioRobotics Stock Holdings

This Form 3 filing discloses the initial statement of beneficial ownership by Barry L. Templin, Executive Vice President and Chief Technology Officer of PROCEPT BioRobotics Corp. The filing reports ownership of 69,311 shares of common stock directly and 56,457 shares indirectly through the Templin Trust dated February 3, 2020. Additionally, Templin holds multiple stock option grants with varying exercise prices and expiration dates through 2036. The options include grants from 2023-2026 with exercise prices ranging from $5.18 to $60.60 per share. The filing also includes restricted stock units (RSUs) that vest quarterly over time, with one-quarter vesting on the anniversary of the grant date and the remainder vesting quarterly thereafter. This represents the standard disclosure of executive equity compensation and ownership in the company.